| scholarly article | Q13442814 |
| P2093 | author name string | Perl DP | |
| Lesser G | |||
| Davis KL | |||
| Libow L | |||
| Prohovnik I | |||
| Haroutunian V | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| dementia | Q83030 | ||
| P304 | page(s) | 49-55 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease | |
| P478 | volume | 66 |
| Q94416316 | Q94416316 |
| Q38841003 | "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). |
| Q90140035 | A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia |
| Q36884053 | A neuronal DNA damage response is detected at the earliest stages of Alzheimer's neuropathology and correlates with cognitive impairment in the Medical Research Council's Cognitive Function and Ageing Study ageing brain cohort |
| Q42908288 | A nonhuman primate model of Alzheimer's disease generated by intracranial injection of amyloid-β42 and thiorphan. |
| Q37155545 | APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. |
| Q35987278 | APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study |
| Q46320596 | APP/Aβ structural diversity and Alzheimer's disease pathogenesis |
| Q30486197 | Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia |
| Q36491332 | Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease |
| Q29616743 | Alzheimer's disease |
| Q35231770 | Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies |
| Q27009411 | Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease |
| Q24648007 | Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo |
| Q33689424 | Amyloid imaging in mild cognitive impairment subtypes. |
| Q30436083 | Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. |
| Q30382595 | Changing perspectives regarding late-life dementia. |
| Q37351456 | Cholinergic Depletion in Alzheimer's Disease Shown by [ (18) F]FEOBV Autoradiography |
| Q36892879 | Classifying late-onset dementia with MRI: is arteriosclerotic brain degeneration the most common cause of Alzheimer's syndrome? |
| Q34554590 | Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity |
| Q34061233 | Cognition, glucose metabolism and amyloid burden in Alzheimer's disease |
| Q24599735 | Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease |
| Q48506103 | Cortical hypermetabolism in MCI subjects: a compensatory mechanism? |
| Q57724897 | Dementia in the oldest old |
| Q53072429 | Development of novel PET probe [¹¹C](R,R)HAPT and its stereoisomer [¹¹C](S,S)HAPT for vesicular acetylcholine transporter imaging: a PET study in conscious monkey. |
| Q37417661 | Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology |
| Q36042420 | Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype. |
| Q35188332 | Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease |
| Q36560884 | Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study |
| Q35792038 | FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? |
| Q33513475 | Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals |
| Q35168684 | Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects |
| Q36536430 | In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease |
| Q37406173 | Interaction of neuritic plaques and education predicts dementia |
| Q33851687 | Interactive effects of vascular risk burden and advanced age on cerebral blood flow |
| Q34776816 | Is there a neuropathology difference between mild cognitive impairment and dementia? |
| Q34606557 | Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease |
| Q34551022 | Memory activation in healthy nonagenarians |
| Q35606753 | Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old |
| Q37677417 | Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old |
| Q28088701 | Preventing Alzheimer's disease by means of natural selection |
| Q34372593 | Rates of decline in Alzheimer disease decrease with age. |
| Q48741820 | Regional analysis of striatal and cortical amyloid deposition in patients with Alzheimer's disease. |
| Q37739881 | Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition |
| Q38904336 | Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role. |
| Q34764490 | Role of the neuropathology of Alzheimer disease in dementia in the oldest-old |
| Q35868776 | Synaptic protein deficits are associated with dementia irrespective of extreme old age |
| Q37041385 | The New Criteria for Alzheimer's Disease - Implications for Geriatricians |
| Q37166455 | The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction |
| Q53122183 | The autopsy and the elderly patient in the hospital and the nursing home: enhancing the quality of life. |
| Q37964897 | The neuropathological profile of mild cognitive impairment (MCI): a systematic review. |
Search more.